Statements of Cash Flows - USD ($)	12 Months Ended
	Feb. 29, 2024	Feb. 28, 2023
Cash Flows from Operating Activities:
Net loss	$ (661,965)	$ (315,524)
Adjustments to reconcile net loss to net cash used in operating activities:
Impairment expense		46,063
Common stock issued for services	197,844
Adjustment for reverse merger		(189,911)
Depreciation expense		5,133
Changes in operating assets and liabilities:
Inventory	(479)	(2,611)
Prepaids	(8,397)	31,673
Note receivable	(15,000)
Accounts payable and accrued expenses	(51,400)	(22,955)
Accrued interest – related party	77,790
Accrued officer compensation	120,000	144,800
Net cash used in operating activities	(341,607)	(303,332)
Cash Flows from Investing Activities
Cash Flows from Financing Activities:
Proceeds from the sale of common stock		660,000
Repayment of loan payable		(7,240)
Repayment of related party loan	(149,156)	(1,557)
Net cash used in financing activities	(149,156)	651,203
Net change in cash	(490,763)	347,871
Cash, beginning of period	114,851	319,980
Funds held in escrow, beginning of period	553,000
Cash, end of period	177,088	667,851
Supplemental disclosures of cash flow information:
Interest paid
Income tax paid
Supplemental disclosure of non-cash activity:
Common stock issued for services prior to reverse merger		337,500
Common stock issued for services prior to reverse merger – related party		$ 67,500